Other companies make claims. We sponsor the clinical research.
ABSC Organics believes in our product and in the power of CBD to improve your pet’s wellness and quality of life. But we know there’s a difference between belief and proof–between anecdotal stories and clinical evidence. We care about that difference, and we care about pets. That’s why we’re the only veterinary CBD company who has sponsored a Phase One Safety and Toxicity Study.
ABSC Pure Organic CBD Oil: Proven safe and well-tolerated in the first and only veterinary safety trial.
With ABSC sponsorship, Colorado State University’s College of Veterinary Medicine and Biomedical Sciences took the lead in veterinary CBD research in 2016. Using our product, Dr. Stephanie McGrath and her team at CSU investigated the safety of specified combinations and delivery methods of our hemp-hybrid oil extract in dogs. The results confirmed that dogs tolerated clinical doses of the compound found in C.H.O. Pet Tincture without adverse effects. These results were presented at the Institute of Cannabis Research Conference at CSU-Pueblo on April 29, 2017, and were published in the Fall 2018 issue of the Journal of the American Holistic Veterinary Medical Association.
Phase 2 Clinical Trials for Epilepsy and Arthritis Using ABSC Pure Organic CBD Oil
Dr. McGrath completed a pilot epilepsy study in 2018, and the promising results of that study were published in the June 1 issue of the Journal of the American Veterinary Medical Association. Dr. McGrath reported that 89% of the dogs in the small pilot study showed a reduction in seizure frequency. A larger epilepsy study, sponsored by the AKC Canine Health Foundation, is ongoing at CSU, as is an arthritis study. In each study, ABSC is supplying the CBD oil–made with the very same CBD you can buy for your pet here on our site.